Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply.
Publication
, Journal Article
Piccini, JP; Patel, MR; Caso, V; OCEANIC-AF Steering Committee and Investigators
Published in: N Engl J Med
March 27, 2025
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 27, 2025
Volume
392
Issue
12
Start / End Page
1247 / 1248
Location
United States
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., Patel, M. R., Caso, V., & OCEANIC-AF Steering Committee and Investigators. (2025). Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply. N Engl J Med, 392(12), 1247–1248. https://doi.org/10.1056/NEJMc2501201
Piccini, Jonathan P., Manesh R. Patel, Valeria Caso, and OCEANIC-AF Steering Committee and Investigators. “Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply.” N Engl J Med 392, no. 12 (March 27, 2025): 1247–48. https://doi.org/10.1056/NEJMc2501201.
Piccini JP, Patel MR, Caso V, OCEANIC-AF Steering Committee and Investigators. Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply. N Engl J Med. 2025 Mar 27;392(12):1247–8.
Piccini, Jonathan P., et al. “Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply.” N Engl J Med, vol. 392, no. 12, Mar. 2025, pp. 1247–48. Pubmed, doi:10.1056/NEJMc2501201.
Piccini JP, Patel MR, Caso V, OCEANIC-AF Steering Committee and Investigators. Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply. N Engl J Med. 2025 Mar 27;392(12):1247–1248.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 27, 2025
Volume
392
Issue
12
Start / End Page
1247 / 1248
Location
United States
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences